Cargando…
Navigating Evidence, Challenges, and Caution in the Treatment of Stimulant Use Disorders
Amidst the opioid epidemic, harm reduction-oriented approaches have gained traction, including interventions that focus on prescribing pharmaceutical-grade psychoactive substances, such as opioids, instead of illicit versions, intending to mitigate fatal overdose risks arising from the variability i...
Autores principales: | Bahji, Anees, Danilewitz, Marlon, Crockford, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605120/ https://www.ncbi.nlm.nih.gov/pubmed/37891785 http://dx.doi.org/10.3390/brainsci13101416 |
Ejemplares similares
-
Evidence base to support using prescribed psychostimulants to treat psychostimulant use disorder is limited
por: Bahji, Anees, et al.
Publicado: (2023) -
The Rising Tide of Stimulant-Related Morbidity and Mortality Warrants Evidence-Based Treatment
por: Bahji, Anees, et al.
Publicado: (2022) -
Unexpected turn of events: Completing residency in the COVID-19 era
por: Danilewitz, Marlon, et al.
Publicado: (2020) -
Towards competency-based medical education in addictions psychiatry: a systematic review
por: Bahji, Anees, et al.
Publicado: (2021) -
Comment on “I’m Virtually a Psychiatrist: Problems with Telepsychiatry in Training”
por: Danilewitz, Marlon, et al.
Publicado: (2022)